Relmada Therapeutics Inc. Common Stock (RLMD)
FairStock Score: 25/100 — RISKY
| Current Price | $7.17 |
| Market Cap | $75,16,53,824 |
| P/E Ratio | — |
| ROE | -25.62% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology
FairStock Score: 25/100 — RISKY
| Current Price | $7.17 |
| Market Cap | $75,16,53,824 |
| P/E Ratio | — |
| ROE | -25.62% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology